The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Europe weight management market size reached US$ 113.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 165.6 Billion by 2027, exhibiting a growth rate (CAGR) of 6.67% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Weight management aids individuals in maintaining a healthy body weight according to their height, gender and age. It also helps improve the immune system, fertility and sleep routine by incorporating appropriate treatments and encouraging healthy living habits. It promotes the consumption of green tea/herbal tea, meal replacement products, low-calory food and beverages and weight loss/gain supplements. Presently, the rising prevalence of chronic diseases is positively influencing the demand for these services in Europe.
With the growing health-consciousness among individuals, the leading players are creating nutritious and tasty diet plans. Moreover, they are investing hefty amounts in celebrity endorsements to increase their sales and expand the overall consumer base. They are also opening gyms in corporate premises, which, in turn, is propelling the growth of the weight management market in Europe.
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe weight management market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on diet, equipment and service.
Breakup by Diet:
Breakup by Equipment:
Breakup by Service:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2021|
|Segment Coverage||Diet, Equipment, Service, Country|
|Countries Covered||Germany, France, United Kingdom, Italy, Spain, Others|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at